| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/11/2009 | WO2009055289A3 Therapeutic substituted lactams |
| 06/11/2009 | WO2009055053A3 Diarylhydantoin compounds as androgen receptor modulators |
| 06/11/2009 | WO2009053895A3 Quinoline urotensin-ii receptor antagonists |
| 06/11/2009 | WO2009053804A3 Idarubicin for the treatment of lymphoma in a dog |
| 06/11/2009 | WO2009052264A3 Maleate salts of (e)-n-{4-[3-chloro-4-(2-pyridinylmethoxy)anilino]-3-cyano-7-ethoxy-6-quinolinyl}-4-(dimethylamino)-2-butenamide and crystalline forms thereof |
| 06/11/2009 | WO2009051718A3 Calcium receptor modulating agents |
| 06/11/2009 | WO2009049820A3 Amorphous formulation |
| 06/11/2009 | WO2009049214A3 Inhibition and treatment of prostate cancer metastasis |
| 06/11/2009 | WO2009047499A3 Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes |
| 06/11/2009 | WO2009044006A3 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxylic acid the pharmaceutically-acceptable esters and salts and solvates thereof for use as medicament |
| 06/11/2009 | WO2009039246A3 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection |
| 06/11/2009 | WO2009037183A3 Cosmetic and/or pharmaceutical preparation containing nucleic acid for the induction of antimicrobial peptides in epithelia |
| 06/11/2009 | WO2009033047A3 Methods and compositions for treating diseases and conditions involving higher molecular weight hyaluronan |
| 06/11/2009 | WO2009032123A3 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 06/11/2009 | WO2009027811A3 Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl) -amino) -methyl) -phenoxy) -acetic acid sodium salt or a hydrate thereof and methods for making the same |
| 06/11/2009 | WO2009019294A9 Bupropion hydrobromide and therapeutic applications |
| 06/11/2009 | WO2009016516A3 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use |
| 06/11/2009 | WO2009014759A3 Methods of inhibiting vzv replication and related compositions |
| 06/11/2009 | WO2009013212A3 Dual modulators of 5-ht2a and d3 receptors |
| 06/11/2009 | WO2009012908A3 Medicament for transdermal use on animals |
| 06/11/2009 | WO2009008920A3 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning |
| 06/11/2009 | WO2008155390A3 Use of inhibitors of sirtuins and/or ampk for the preparation of a medicament for the treatment of polyalanine diseases. |
| 06/11/2009 | WO2008150897A3 Reduction of off-target rna interference toxicity |
| 06/11/2009 | WO2008150495A8 vWF APTAMER FORMULATIONS AND METHODS FOR USE |
| 06/11/2009 | WO2008147373A3 Methods and compositions for reducing body weight using an estrogen fatty ester in an oil |
| 06/11/2009 | WO2008135524A3 Substituted anthranilamides and analogues, manufacturing and use thereof as medicaments |
| 06/11/2009 | WO2008122994A3 Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof |
| 06/11/2009 | WO2008063300A8 Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
| 06/11/2009 | WO2008060907A3 Pyrrolo-pyridine kinase inhibitors |
| 06/11/2009 | WO2008046758A3 Imidazolone and imidazolidinone derivatives as 11b-hsd1 inhibitors for diabetes |
| 06/11/2009 | WO2008042795A3 Histone acetyle transferase activators and histone deacetylase inhibitors in the treatment of alcoholism |
| 06/11/2009 | WO2007109871A3 Acridine derivatives with antitumoral activity |
| 06/11/2009 | WO2006132675A3 Xiap-targeted prostate cancer therapy |
| 06/11/2009 | WO2006125166A3 Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer |
| 06/11/2009 | WO2006119504A3 Fused heterocyclic compounds, and compositions and uses thereof |
| 06/11/2009 | WO2006074146A3 Use of 3-substituted-2-(diphenylmethy)-1-azabicyclo[2.2.2]octanes for treating mrg-x1 receptor mediated diseases |
| 06/11/2009 | WO2005095402A9 Substituted 1,4,8-triazaspiro[4.5]decan-2-on compounds for use in the treatment of obesity |
| 06/11/2009 | WO2003028622A3 Method of delivering drugs to a tissue using drug-coated medical devices |
| 06/11/2009 | WO2003022211A3 Method of preventing mucositis |
| 06/11/2009 | WO2003011214A3 Novel methods and formulations for administration of active agents |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | WO2002065984A3 Compounds having retinoid-like activity |
| 06/11/2009 | WO2002030358A3 Modulation of ccr4 function |
| 06/11/2009 | WO2002003918A3 Treating neural conditions resulting from spinal cord contusions and other causes |
| 06/11/2009 | WO2001070093A3 Agents and methods for the prevention of initial onset of cancers, the treatment of cancers, and the recurrence of existing cancers |
| 06/11/2009 | US20090151013 Modified ES cells and ES cell-specific genes |
| 06/11/2009 | US20090149833 Implantable Drug Delivery Device and Methods for Treatment of the Bladder and Other Body Vesicles or Lumens |
| 06/11/2009 | US20090149823 Application of Polymeric Materials to Screens To Facilitate Hemostasis And Wound Healing |
| 06/11/2009 | US20090149822 Apparatus having a fibrous skin-contactable element containing an agent |
| 06/11/2009 | US20090149799 Method for chemical modulation of neural activity |
| 06/11/2009 | US20090149652 Affinity for somatostatin receptors; used for the treatment of acromegalia, hypophyseal adenomas or endocrine gastroenteropancreatic tumors including carcinoid syndrome; 4-(urea or thiourea substituted)-1-alkylpiperidines |
| 06/11/2009 | US20090149650 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors |
| 06/11/2009 | US20090149551 OXIDIZED cis-TERPENONE AND ITS USE AS A CHEMOPROTECTIVE AND ANTI-MALARIAL AGENT |
| 06/11/2009 | US20090149550 Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
| 06/11/2009 | US20090149549 Preparation of chiral amides and amines |
| 06/11/2009 | US20090149548 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 06/11/2009 | US20090149546 Enhanced Bimatoprost Ophthalmic Solution |
| 06/11/2009 | US20090149545 Treatment of coronavirus infection |
| 06/11/2009 | US20090149544 Alpha-aminoamide derivatives |
| 06/11/2009 | US20090149543 Solid pharmaceutical compositions comprising lumiracoxib |
| 06/11/2009 | US20090149542 Administering 2-hydroxy-5-(2-(4-trifluoromethyl-phenyl)ethylamino)-benzoic acid |
| 06/11/2009 | US20090149541 Method of delaying the onset of clinically definite multiple sclerosis |
| 06/11/2009 | US20090149540 Compositions and Methods for Attenuating Mitochondria-Mediated Cell Injury |
| 06/11/2009 | US20090149539 Pet food compositions and methods |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/11/2009 | US20090149537 Use of Bile Acid or Bile Salt Fatty Acid Conjugates |
| 06/11/2009 | US20090149536 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders |
| 06/11/2009 | US20090149535 3-carboxypropyl-aminotetralin derivatives and related compounds as mu opioid receptor antagonists |
| 06/11/2009 | US20090149534 Crystalline modifications of (1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| 06/11/2009 | US20090149533 Novel fenofibrate formulations and related methods of treatment |
| 06/11/2009 | US20090149532 Herpesvirus-derived therapeutic agent for pain |
| 06/11/2009 | US20090149531 Chemical composition derived from p-hydroxyphenyl propionic acid for the treatment of psoriasis |
| 06/11/2009 | US20090149530 Antiinfective Flavonol Compounds and Methods of Use Thereof |
| 06/11/2009 | US20090149529 Antioxidant-Containing Food Composition For Use In Enhancing Antiviral Immunity In Companion Animals |
| 06/11/2009 | US20090149528 Cinnamic acid amides |
| 06/11/2009 | US20090149527 Apparatus and Method for Application of a Pharmaceutical to a Surface of an External Ear Canal for Treatment of Keratosis Obutrans |
| 06/11/2009 | US20090149526 Tetracyclic Indole Derivatives as Antiviral Agents |
| 06/11/2009 | US20090149525 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy |
| 06/11/2009 | US20090149524 N-(Phenylmethyl)-2-(1H-Pyrazol-4-yl) Acetamide Derivatives as P2X7 Antagonists for the Treatment of Pain, Inflammation and Neurodegeneration |
| 06/11/2009 | US20090149523 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases |
| 06/11/2009 | US20090149521 Dual-acting benzoimidazole antihypertensive agents |
| 06/11/2009 | US20090149520 Oxazolidinones containing oxindoles as antibacterial agents |
| 06/11/2009 | US20090149519 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments |
| 06/11/2009 | US20090149518 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 06/11/2009 | US20090149517 Novel 2-substituted tiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals |
| 06/11/2009 | US20090149516 desoxyepothilone A and B; Fludelone; anticarcinogenic agents; drug resistance; water solubility for formulability; industrial scale; cytotoxic or growth inhibitory effects on CAG myeloma cells lines; ability to polymerize tubulin; minimum toxicity; isomerization of the double bonds in the ring |
| 06/11/2009 | US20090149515 Treatments for the control of schistosomiasis |
| 06/11/2009 | US20090149514 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/11/2009 | US20090149513 Compositions of an Orally Active 1,2,4-Oxadiazole for Nonsense Mutation Suppression Therapy |
| 06/11/2009 | US20090149512 Use of Ghrelin Antagonists to the Treatment of Certain CNS Diseases |
| 06/11/2009 | US20090149511 Administration of an Inhibitor of HDAC and an mTOR Inhibitor |
| 06/11/2009 | US20090149510 Compositions and methods for modulating a kinase cascade |
| 06/11/2009 | US20090149509 Peptidyl deformylase inhibitors used for inhibiting bacteria or preventing bacterial contamination of a cell culture medium; 2 (S)-hydroxy-3 (R)-[2 (S)-oxazol-2-yl-pyrrolidine-1-carbonyl)-heptanoic acid hydroxamide |
| 06/11/2009 | US20090149508 Process for the preparation of substituted phenyl ether compounds |
| 06/11/2009 | US20090149507 Method for customized dispensing of variable dose drug combination products for individualizing of therapies |
| 06/11/2009 | US20090149506 Insecticidal compositions with improved effect |
| 06/11/2009 | US20090149505 Metabotropic Glutamate Receptor-Potentiating Isoindolones |
| 06/11/2009 | US20090149504 Novel 5-Substituted Indole Derivatives As Dipeptidyl Peptidase IV (DPP-IV) Inhibitors |
| 06/11/2009 | US20090149503 New 5-aryl pyridines as 11-beta inhibitors for the treatment of diabetes |
| 06/11/2009 | US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders |